When the Next Step Isn't Clear, Start With Evidence
An independent information platform that helps referring oncologists explore international treatment options, clinical trials, access conditions, and practical feasibility — without replacing clinical judgment or the patient's own decision-making.
CancerCareE is not a hospital, not a treatment provider, and not a conventional medical tourism agency. We organize publicly available evidence and access information into a structured, verifiable format.
Quick Answer
For patients who have exhausted standard local pathways, CancerCareE helps referring physicians identify and evaluate potential next-step options — including clinical trials, therapies approved in other jurisdictions, and access conditions across multiple countries. All information is aggregated from public sources and partner institutions, and every output is designed to support — not replace — the treating physician's judgment.
A Reality Check
Common assumption: "A coordination platform will manage the patient's treatment and guarantee an outcome."
Reality: CancerCareE provides structured information, access pathways, and introductions to partner institutions. Clinical decisions remain with the treating physician and the patient. We do not guarantee outcomes, we do not provide medical care, and our role ends once a direct connection is established.
What This Page Is — and What It Is Not
This platform IS
- An independent information and pathway-navigation resource
- A structured starting point for evaluating next-step options
- A bridge to partner institutions and clinical trial information
- Transparent about funding and limitations
This platform IS NOT
- A hospital, clinic, or treatment provider
- A substitute for clinical judgment or multidisciplinary review
- A guarantee of access, eligibility, or outcome
- A medical tourism agency selling packages
What We Provide for Referring Physicians
Three areas where structured information may help a physician decide whether an international pathway is worth exploring further.
Treatment Pathway Information
When local guidelines have been exhausted, we help organize the patient's clinical context against publicly available information on therapies, regulatory status, and access conditions across multiple jurisdictions.
- Public-source mapping of potential next-step options
- Regulatory and access conditions by country
- Links to primary literature and trial registries
- Documented uncertainty and information gaps
- Referring physician retains full clinical oversight
Clinical Trial Information
We help physicians locate potentially relevant trials from public registries and partner institutions, and clarify what additional information is needed before a formal eligibility check.
- Search by cancer type, molecular target, and country
- Direct links to official registry records
- Distinction between "trial found" and "site confirmed"
- Eligibility criteria from authoritative sources
- Open questions to discuss with the site
International Access & Feasibility
For options that appear relevant, we help clarify practical feasibility — what access requires, what remains uncertain, and what questions to ask a partner institution before considering referral.
- General cost categories (not binding quotes)
- Documentation and admission requirements
- Visa, accommodation, and language considerations
- Continuity of care after return
- Explicitly flagged uncertainties
How a Review Typically Unfolds
A structured, transparent process — designed to reduce the number of steps needed to reach a useful next action.
Initial question
The physician submits a structured summary of the clinical context — no full medical records, no identifiable patient data.
Information gathering
Public sources, registries, and partner institutions are consulted for options and access conditions.
Structured brief
A one-page brief lists identified options, evidence level, access status, and open questions.
Physician decision
The referring physician decides whether any pathway merits further exploration with the patient.
What to Consider Before Referral
A general framework for evaluating whether an international pathway is worth exploring further. This is illustrative and does not represent specific recommendations.
| Clinical Need | Required Capability | Potential Access Paths |
|---|---|---|
| Patient has exhausted standard local treatment lines | Availability of investigational or regionally approved therapies | Public trial registries; partner institutions; documented access requirements |
| Rare molecular target with limited published data | Site-specific experience and protocol availability | Registry-based trial search; direct site inquiry; peer literature review |
| Therapy approved in one jurisdiction but not another | Regulatory status and cross-border access conditions | Regulatory authority records; partner institution confirmation |
| Patient requires treatment coordination abroad | Feasibility of travel, documentation, and continuity of care | Partner institutions; documented logistics and repatriation planning |
Funding and Limitations
How This Service Is Funded
CancerCareE is free for physicians and patients to use for information and introduction services. After a patient is introduced to a partner institution, CancerCareE may receive a fixed referral fee from that institution.
This fee is not performance-based and does not determine which institution is suggested. Recommendations are based on publicly available clinical trial information, hospital accreditation status, and treatment protocols.
What We Cannot Do
We do not provide medical care, diagnose conditions, or recommend specific treatments. We do not guarantee access, eligibility, outcomes, or timelines. We cannot confirm enrollment until a partner institution independently reviews a case.
Information on this platform is a starting point. All clinical decisions remain with the treating physician and the patient, based on a full review of the individual's medical records and a realistic assessment of risks and benefits.
Data Handling
CancerCareE is designed to minimize the handling of sensitive data. No full medical records are requested through this platform. Any information shared for an initial review should be de-identified and limited to the clinical context needed to understand the question.
We do not store personal health information on this website. Data protection practices are aligned with international best-practice principles; specific technical and legal details are available on request.
Who This Service Is Designed For
Typical users
- Board-certified oncologists and hematologists
- Physicians treating rare or complex cancers
- Clinical trial investigators
- Academic oncology researchers
- Hospital international referral coordinators
Not intended for
- Non-licensed practitioners
- Commercial entities seeking patient data
- Requests for direct patient recruitment
- Individuals misrepresenting credentials
- Use as a substitute for clinical judgment
Frequently Asked Questions
How does CancerCareE help when standard oncology pathways have been exhausted?
CancerCareE organizes publicly available information about potential next-step options — including clinical trials, therapies approved in other jurisdictions, and access conditions — into a structured brief that a referring physician can review. It does not replace clinical judgment and does not provide medical advice.
How is CancerCareE funded if services are free?
CancerCareE may receive a fixed referral fee from partner institutions after a patient is introduced. This fee is not performance-based and does not determine which institution is suggested. Full details are available on the financial transparency page.
What information is needed to begin a review?
Only the clinical context required to understand the question — for example, cancer type, prior lines of therapy, relevant molecular findings, and the specific clinical question the physician is trying to answer. No full medical records or identifiable patient data are requested through this platform.
Does CancerCareE guarantee access, eligibility, or outcomes?
No. All decisions about access, eligibility, and treatment are made by the partner institution and the treating physician. CancerCareE provides information and introductions only.
How is patient data handled?
CancerCareE is designed to minimize the handling of sensitive data. No full medical records are requested through this platform. Any information shared for an initial review should be de-identified and limited to the clinical context. Personal health information is not stored on this website.
What is CancerCareE's role exactly?
CancerCareE is an independent information and introduction platform — not a healthcare provider. We organize evidence and access information, and connect referring physicians with partner institutions when a pathway appears worth exploring.
Explore Options for Your Patient
Start with a structured, evidence-based review — at no cost to physicians or patients.
Explore Related Information
Clinical Trials Overview
Registry-based information on trials and eligibility concepts
Advanced Therapies
General information on cell therapy modalities and targets
Cost Transparency
General cost categories for treatment abroad
Financial Transparency
How CancerCareE is funded and how conflicts are managed
Sources and Further Reading
- U.S. National Library of Medicine — ClinicalTrials.gov. Public registry of clinical studies. Available at: clinicaltrials.gov
- World Health Organization — International Clinical Trials Registry Platform (ICTRP). Global trial registry network. Available at: who.int/clinical-trials-registry-platform
- U.S. Food and Drug Administration — Oncology guidance documents. Available at: fda.gov
- European Medicines Agency — Oncology product information. Available at: ema.europa.eu
- National Medical Products Administration (NMPA), China — Regulatory information. Available at: nmpa.gov.cn
- PubMed — Biomedical literature database. Available at: pubmed.ncbi.nlm.nih.gov